These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 22938654)
1. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. Rink M; Lee DJ; Kent M; Xylinas E; Fritsche HM; Babjuk M; Brisuda A; Hansen J; Green DA; Aziz A; Cha EK; Novara G; Chun FK; Lotan Y; Bastian PJ; Tilki D; Gontero P; Pycha A; Baniel J; Mano R; Ficarra V; Trinh QD; Tagawa ST; Karakiewicz PI; Scherr DS; Sjoberg DD; Shariat SF; BJU Int; 2013 Mar; 111(3 Pt B):E30-6. PubMed ID: 22938654 [TBL] [Abstract][Full Text] [Related]
2. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. Rink M; Hansen J; Cha EK; Green DA; Babjuk M; Svatek RS; Xylinas E; Tagawa ST; Faison T; Novara G; Karakiewicz PI; Daneshmand S; Lotan Y; Kassouf W; Fritsche HM; Pycha A; Comploj E; Tilki D; Bastian PJ; Chun FK; Dahlem R; Scherr DS; Shariat SF BJU Int; 2013 Jan; 111(1):74-84. PubMed ID: 22809039 [TBL] [Abstract][Full Text] [Related]
3. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503 [TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy. Bruins HM; Wopat R; Mitra AP; Cai J; Miranda G; Skinner EC; Daneshmand S BJU Int; 2013 Mar; 111(3 Pt B):E37-42. PubMed ID: 22974410 [TBL] [Abstract][Full Text] [Related]
5. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
6. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. Mitra AP; Quinn DI; Dorff TB; Skinner EC; Schuckman AK; Miranda G; Gill IS; Daneshmand S BJU Int; 2012 Mar; 109(6):846-54. PubMed ID: 21812902 [TBL] [Abstract][Full Text] [Related]
7. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy. Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623 [TBL] [Abstract][Full Text] [Related]
8. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854 [TBL] [Abstract][Full Text] [Related]
9. Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy. Xylinas E; Rink M; Novara G; Green DA; Clozel T; Fritsche HM; Guillonneau B; Lotan Y; Kassouf W; Tilki D; Babjuk M; Karakiewicz PI; Montorsi F; Abdennabi J; Trinh QD; Svatek RS; Scherr DS; Zerbib M; Shariat SF Ann Surg Oncol; 2013 Mar; 20(3):1027-34. PubMed ID: 23099729 [TBL] [Abstract][Full Text] [Related]
10. Marital status: a gender-independent risk factor for poorer survival after radical cystectomy. Sammon JD; Morgan M; Djahangirian O; Trinh QD; Sun M; Ghani KR; Jeong W; Jhaveri J; Ehlert M; Schmitges J; Bianchi M; Shariat SF; Perrotte P; Rogers CG; Peabody JO; Menon M; Karakiewicz PI BJU Int; 2012 Nov; 110(9):1301-9. PubMed ID: 22449122 [TBL] [Abstract][Full Text] [Related]
11. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors. Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156 [TBL] [Abstract][Full Text] [Related]
12. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245 [TBL] [Abstract][Full Text] [Related]
13. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. Chromecki TF; Cha EK; Fajkovic H; Rink M; Ehdaie B; Svatek RS; Karakiewicz PI; Lotan Y; Tilki D; Bastian PJ; Daneshmand S; Kassouf W; Durand M; Novara G; Fritsche HM; Burger M; Izawa JI; Brisuda A; Babjuk M; Pummer K; Shariat SF BJU Int; 2013 Feb; 111(2):249-55. PubMed ID: 22727036 [TBL] [Abstract][Full Text] [Related]
15. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Kluth LA; Xylinas E; Rieken M; El Ghouayel M; Sun M; Karakiewicz PI; Lotan Y; Chun FK; Boorjian SA; Lee RK; Briganti A; Rouprêt M; Fisch M; Scherr DS; Shariat SF BJU Int; 2014 Mar; 113(3):393-8. PubMed ID: 24053618 [TBL] [Abstract][Full Text] [Related]
16. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804 [TBL] [Abstract][Full Text] [Related]
17. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174 [TBL] [Abstract][Full Text] [Related]
18. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. Shariat SF; Svatek RS; Tilki D; Skinner E; Karakiewicz PI; Capitanio U; Bastian PJ; Volkmer BG; Kassouf W; Novara G; Fritsche HM; Izawa JI; Ficarra V; Lerner SP; Sagalowsky AI; Schoenberg MP; Kamat AM; Dinney CP; Lotan Y; Marberger MJ; Fradet Y BJU Int; 2010 May; 105(10):1402-12. PubMed ID: 20132195 [TBL] [Abstract][Full Text] [Related]
19. Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome. Turker P; Bostrom PJ; Wroclawski ML; van Rhijn B; Kortekangas H; Kuk C; Mirtti T; Fleshner NE; Jewett MA; Finelli A; Kwast TV; Evans A; Sweet J; Laato M; Zlotta AR BJU Int; 2012 Sep; 110(6):804-11. PubMed ID: 22321341 [TBL] [Abstract][Full Text] [Related]
20. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection. Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]